Weekly Utidelone in HER2-negative Inoperable Locally Advanced or Metastatic Breast Cancer

NCT05403333 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms
Locally Advanced or Metastatic Breast Cancer

Interventions

DRUG: utidelone

Sponsor

Fudan University